[AL23] Daiichi Sankyo

11:05 AM - 11:45 AM JST(2:05 AM - 2:45 AM UTC)

[AL23] Creation of trastuzumab deruxtecan, a novel cancer treatment drug, by innovating new-generation antibody-drug conjugate technology, DXd-ADC

Toshinori Agatsuma¹, ○Yuki Abe¹, Hiroyuki Naito¹, Takashi Nakada¹, Yusuke Ogitani¹ (1. Daiichi Sankyo)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.